copper gluconate has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelazim, AH; Abdelazim, MH | 1 |
| Finzi, E | 1 |
| Bittel, B; Desai, MY; Il'Giovine, ZJ; Kumar, A; McWilliams, C; Mehra, R; Nissen, SE; Patel, D; Thomas, S; Wang, Q; Wolski, K | 1 |
| Audoux, E; Botelho-Nevers, E; Bourlet, T; Dickerscheit, Y; Pillet, S; Pozzetto, B; Prier, A; Rigaill, J; Rodriguez, K; Saunier, F; Verhoeven, PO | 1 |
2 trial(s) available for copper gluconate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Post COVID-19 Infection.
Topics: Calcium; Chelating Agents; COVID-19; COVID-19 Drug Treatment; Gluconates; Humans; Olfaction Disorders; Prospective Studies; Smell; Sodium Chloride; Water | 2022 |
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
Topics: Adult; Ambulatory Care; Antioxidants; Ascorbic Acid; Cough; COVID-19; COVID-19 Drug Treatment; Dietary Supplements; Dyspnea; Fatigue; Female; Fever; Gluconates; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Standard of Care; Trace Elements; Treatment Outcome; Zinc | 2021 |
2 other study(ies) available for copper gluconate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients.
Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Dyspnea; Female; Gluconates; Humans; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; SARS-CoV-2; Zinc Acetate | 2020 |
Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening.
Topics: Animals; Antiviral Agents; Cell Survival; Chlorocebus aethiops; COVID-19; Gluconates; Green Fluorescent Proteins; Microscopy, Confocal; SARS-CoV-2; Vero Cells | 2021 |